Sabahat Zahra Siddiqui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sabahat Zahra Siddiqui has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Athar Abbasi
Department of Chemistry Government College University Lahore Pakistan
17 shared publications - Aziz- Ur- Rehman
Department of Chemistry, Government College University, Lahore 54000, Pakistan
12 shared publications - Syed Adnan Ali Shah
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Kampus Puncak Alam, Bandar Puncak Alam, Malaysia
10 shared publications - Shahid Rasool
Department of Chemistry, Government College University, Lahore 54000, Pakistan
5 shared publications Aziz- Ur- Rehman
4 shared publicationsAzizur Rehman
Department of Chemistry, Government College University, Lahore, Pakistan
4 shared publications
Latest Publications
- Open Access
- 29 September 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (39) , 45191-45203
Design, Synthesis, and Computational Studies of Novel N-(Substituted phenyl)-3-(5-((naphthalen-2-yloxy)methyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetamides as Potent Acetylcholinesterase Inhibitors
The current studies elaborate the synthesis of some new N-(substituted phenyl)-3-(5-((naphthalen-2-yloxy)methyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetamides (8a–8h). This novel synthesis was accomplished by a well-explained protocol and structural corroboration of derivatives with the help of infrared, electron ionization mass spectrometry, and 1H nuclear magnetic resonance (NMR) and 13C NMR spectral techniques. The in vitro inhibitory potential of newly synthesized acetamides was evaluated against acetylcholinesterase enzyme, and it was explored that all the compounds showed relatively comparable potential as compared to donepezil (IC50 = 0.454 ± 0.076) used as a standard. Among the unique group of these triazoles, compound 8a depicted the maximum inhibition (IC50 = 0.697 ± 0.43). With the outcomes obtained through inhibitory investigation, it was envisaged that these compounds might serve as promising acetylcholinesterase inhibitors and might also lead to a further research gateway for getting safe and nontoxic medicinal derivatives for dealing with acetylcholinesterase-related deformities. Likewise, their bioactivity results were further validated through computational density functional theory and docking analysis to develop the structure–activity relationship finding factors responsible for variable potential through engineering structures with different chemical entities.
- 29 September 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (39) , 45191-45203
Open AccessDesign, Synthesis, and Computational Studies of Novel N-(Substituted phenyl)-3-(5-((naphthalen-2-yloxy)methyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetamides as Potent Acetylcholinesterase Inhibitors
The current studies elaborate the synthesis of some new N-(substituted phenyl)-3-(5-((naphthalen-2-yloxy)methyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetamides (8a–8h). This novel synthesis was accomplished by a well-explained protocol and structural corroboration of derivatives with the help of infrared, electron ionization mass spectrometry, and 1H nuclear magnetic resonance (NMR) and 13C NMR spectral techniques. The in vitro inhibitory potential of newly synthesized acetamides was evaluated against acetylcholinesterase enzyme, and it was explored that all the compounds showed relatively comparable potential as compared to donepezil (IC50 = 0.454 ± 0.076) used as a standard. Among the unique group of these triazoles, compound 8a depicted the maximum inhibition (IC50 = 0.697 ± 0.43). With the outcomes obtained through inhibitory investigation, it was envisaged that these compounds might serve as promising acetylcholinesterase inhibitors and might also lead to a further research gateway for getting safe and nontoxic medicinal derivatives for dealing with acetylcholinesterase-related deformities. Likewise, their bioactivity results were further validated through computational density functional theory and docking analysis to develop the structure–activity relationship finding factors responsible for variable potential through engineering structures with different chemical entities.
- 22 April 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (16)
Synthesis and In Vitro Evaluation of Triazole‐Based N ‐(Substituted phenyl)‐5‐[(benzyl)‐4‐(phenyl)‐4 H ‐1,2,4‐triazol‐3‐ylthio]acetamides as Potent Acetylcholinesterase Inhibitors
The aim of this study was to design and evaluate the potential of some new acetylcholinesterase (AChE) inhibitors, encompassing biologically important acetamides, and 1,2,4‐triazole moieties structural amalgamation. A series of N ‐(substitutedphenyl)‐[5‐(benzyl‐4‐(phenyl‐4 H ‐1,2,4‐triazol‐3‐ylthio)]acetamides ( 8a‐l ) was synthesized through multistep synthetic protocol and their structures were elucidated by modern contemporary spectral techniques, that is, IR, EI‐MS, 1 H‐NMR, and 13 C‐NMR. The in vitro AChE inhibitory activity of the synthesized compounds showed promising results that ranged from IC 50 = 0.017 ± 0.008 to 7.518 ± 0.241 µM as compared to the standard neostigmine methyl sulfate (IC 50 = 2.039 ± 0.051 µM). Among the novel molecules, compound 8j displayed the most potent activity (IC 50 = 0.017 ± 0.008 µM). The kinetics mechanism analyzed by Lineweaver‐Burk Plots revealed that 8j inhibited the AChE enzyme competitively ( K i = 0.008 µM). Furthermore, computational analysis was also performed to provide insights into the binding interactions between compounds and enzymes' active sites, revealing key structural features responsible for their high affinity. These findings suggest that the synthesized acetamide‐triazole derivatives are interesting candidates for AChE inhibition, providing possible avenues for therapeutic interventions in neurodegenerative diseases like alzheimer's disease.
- 22 April 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (16)
Synthesis and In Vitro Evaluation of Triazole‐Based N ‐(Substituted phenyl)‐5‐[(benzyl)‐4‐(phenyl)‐4 H ‐1,2,4‐triazol‐3‐ylthio]acetamides as Potent Acetylcholinesterase Inhibitors
The aim of this study was to design and evaluate the potential of some new acetylcholinesterase (AChE) inhibitors, encompassing biologically important acetamides, and 1,2,4‐triazole moieties structural amalgamation. A series of N ‐(substitutedphenyl)‐[5‐(benzyl‐4‐(phenyl‐4 H ‐1,2,4‐triazol‐3‐ylthio)]acetamides ( 8a‐l ) was synthesized through multistep synthetic protocol and their structures were elucidated by modern contemporary spectral techniques, that is, IR, EI‐MS, 1 H‐NMR, and 13 C‐NMR. The in vitro AChE inhibitory activity of the synthesized compounds showed promising results that ranged from IC 50 = 0.017 ± 0.008 to 7.518 ± 0.241 µM as compared to the standard neostigmine methyl sulfate (IC 50 = 2.039 ± 0.051 µM). Among the novel molecules, compound 8j displayed the most potent activity (IC 50 = 0.017 ± 0.008 µM). The kinetics mechanism analyzed by Lineweaver‐Burk Plots revealed that 8j inhibited the AChE enzyme competitively ( K i = 0.008 µM). Furthermore, computational analysis was also performed to provide insights into the binding interactions between compounds and enzymes' active sites, revealing key structural features responsible for their high affinity. These findings suggest that the synthesized acetamide‐triazole derivatives are interesting candidates for AChE inhibition, providing possible avenues for therapeutic interventions in neurodegenerative diseases like alzheimer's disease.
- 27 October 2021
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 55 (7) , 665-678
Synthesis, Pharmacological Evaluation and Molecular Docking Studies of N-[2-(1H-indol-3-yl)Acetyl]Arylsulfonohydrazides
- 27 October 2021
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 55 (7) , 665-678
Synthesis, Pharmacological Evaluation and Molecular Docking Studies of N-[2-(1H-indol-3-yl)Acetyl]Arylsulfonohydrazides
- 1 January 2019
- Published by Chemical Society of Pakistan in Journal of the chemical society of pakistan
- Vol. 41 (4) , 685
Linear Synthesis of {4-[(2-Alkoxy/aralkyloxy-3,5-dichlorophenyl)sulfonyl]-1-piperazinyl}(2-furyl)methanones as Possible Therapeutic Agents
Journal of the Chemical Society of Pakistan (JCSP) is a bimonthly Journal which publishes results of original, unpublished research work and review articles in all fields of Chemistry.
- 1 January 2019
- Published by Chemical Society of Pakistan in Journal of the chemical society of pakistan
- Vol. 41 (4) , 685
Linear Synthesis of {4-[(2-Alkoxy/aralkyloxy-3,5-dichlorophenyl)sulfonyl]-1-piperazinyl}(2-furyl)methanones as Possible Therapeutic Agents
Journal of the Chemical Society of Pakistan (JCSP) is a bimonthly Journal which publishes results of original, unpublished research work and review articles in all fields of Chemistry.
- Open Access
- 6 December 2018
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF CHEMISTRY
- Vol. 42 (6) , 1459-1478
Synthesis of acetamide derivatives of 1,2,4-triazole bearing azinane and their binding interactions with bovine serum albumin using spectroscopic techniques
- 6 December 2018
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF CHEMISTRY
- Vol. 42 (6) , 1459-1478
Open AccessSynthesis of acetamide derivatives of 1,2,4-triazole bearing azinane and their binding interactions with bovine serum albumin using spectroscopic techniques
- 1 December 2018
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 77, 72-86
2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer’s diseases: In vitro and in silico studies
- 1 December 2018
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 77, 72-86
2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer’s diseases: In vitro and in silico studies
- Open Access
- 8 August 2018
- Published by African Journals Online (AJOL) in Tropical Journal of Pharmaceutical Research
- Vol. 17 (7) , 1397-1406
Synthesis of 3-[4-(2-furoyl)-1-piperazinyl]-N- (substituted)propanamides as promising antibacterial agents with mild cytotoxicity
Purpose: To evaluate the antibacterial activity and cytotoxicity of a series of molecules with amalgamation of furoyl, piperazine and amide moieties. Methods: New derivatives, namely 3-[4-(2-furoyl)-1-piperazinyl]-N-(substituted) propanamides, were synthesized and evaluated for their antibacterial activity and toxicity to mammalian cells. The synthesis was initiated by treating different aryl/aralkyl amines (1a-u) with 3-bromopropionyl chloride (2) to obtain the solid electrophiles 3a-u, which were collected by filtration. Thereafter, the different N-aryl/aralkyl-3- bromopropionamides (3a-u) and 2-furoyl-1-piperazine (4) at equimolar ratios were allowed to react in acetonitrile and in the presence of a base, K2CO3, to form the target compounds, 5a-u. Structural elucidation was carried out using EI-MS (electron impact mass spectrometry), IR (infrared) and 1H-NMR (proton nuclear magnetic resonance). The antibacterial activity of the synthesized compounds was evaluated against various bacterial strains. Furthermore, hemolysis was determined to assess cytotoxicity using bovine red blood cells. Results: Molecules 5g, 5a, 5p, 5g and 5i were found to be potent agents against S. aureus, S. typhi, P. aeruginosa, E. coli and B. subtilis with respective minimum inhibitory concentration (MIC) values of 8.34 ± 0.55, 8.37 ± 0.12, 8.65 ± 0.57, 8.97 ± 0.12 and 9.24 ± 0.50 μM, compared to 7.80 ± 0.19, 7.45 ± 0.58, 7.14 ± 0.58, 7.16 ± 0.58 and 7.29 ± 0.90 μM for the reference standard, ciprofloxacin. The most active compounds, 5a, 5g, 5i and 5p, showed a hemolysis of 15.48, 8.03, 5.52 and 4.35 %, respectively. Conclusion: The synthesized compounds exhibit good antibacterial activity. The hemolysis data indicate that these compounds have a low toxicity level. However, in vivo studies are required to ascertain their potentials as new drug candidates. Keywords: 4-(2-Furoyl)-1-piperazine, 1H-NMR, EI-MS, Antimicrobial activity, Hemolytic activity
- 8 August 2018
- Published by African Journals Online (AJOL) in Tropical Journal of Pharmaceutical Research
- Vol. 17 (7) , 1397-1406
Open AccessSynthesis of 3-[4-(2-furoyl)-1-piperazinyl]-N- (substituted)propanamides as promising antibacterial agents with mild cytotoxicity
Purpose: To evaluate the antibacterial activity and cytotoxicity of a series of molecules with amalgamation of furoyl, piperazine and amide moieties. Methods: New derivatives, namely 3-[4-(2-furoyl)-1-piperazinyl]-N-(substituted) propanamides, were synthesized and evaluated for their antibacterial activity and toxicity to mammalian cells. The synthesis was initiated by treating different aryl/aralkyl amines (1a-u) with 3-bromopropionyl chloride (2) to obtain the solid electrophiles 3a-u, which were collected by filtration. Thereafter, the different N-aryl/aralkyl-3- bromopropionamides (3a-u) and 2-furoyl-1-piperazine (4) at equimolar ratios were allowed to react in acetonitrile and in the presence of a base, K2CO3, to form the target compounds, 5a-u. Structural elucidation was carried out using EI-MS (electron impact mass spectrometry), IR (infrared) and 1H-NMR (proton nuclear magnetic resonance). The antibacterial activity of the synthesized compounds was evaluated against various bacterial strains. Furthermore, hemolysis was determined to assess cytotoxicity using bovine red blood cells. Results: Molecules 5g, 5a, 5p, 5g and 5i were found to be potent agents against S. aureus, S. typhi, P. aeruginosa, E. coli and B. subtilis with respective minimum inhibitory concentration (MIC) values of 8.34 ± 0.55, 8.37 ± 0.12, 8.65 ± 0.57, 8.97 ± 0.12 and 9.24 ± 0.50 μM, compared to 7.80 ± 0.19, 7.45 ± 0.58, 7.14 ± 0.58, 7.16 ± 0.58 and 7.29 ± 0.90 μM for the reference standard, ciprofloxacin. The most active compounds, 5a, 5g, 5i and 5p, showed a hemolysis of 15.48, 8.03, 5.52 and 4.35 %, respectively. Conclusion: The synthesized compounds exhibit good antibacterial activity. The hemolysis data indicate that these compounds have a low toxicity level. However, in vivo studies are required to ascertain their potentials as new drug candidates. Keywords: 4-(2-Furoyl)-1-piperazine, 1H-NMR, EI-MS, Antimicrobial activity, Hemolytic activity